相似文献
1
Future of Care for Patients With Chronic Granulomatous Disease: Gene Therapy and Targeted Molecular Medicine.慢性肉芽肿病患者的未来治疗方案：基因治疗和靶向分子医学。
J Pediatric Infect Dis Soc. 2018 May 9;7(suppl_1):S40-S44. doi: 10.1093/jpids/piy011.
2
Recent Advances in Gene Therapy and Modeling of Chronic Granulomatous Disease.慢性肉芽肿病的基因治疗与建模的最新进展
Iran J Allergy Asthma Immunol. 2019 Apr 1;18(2):131-142.
3
Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous Disease.G1XCGD的非临床疗效和安全性研究，一种用于X连锁慢性肉芽肿病体外基因治疗的慢病毒载体
Hum Gene Ther Clin Dev. 2018 Jun;29(2):69-79. doi: 10.1089/humc.2017.245. Epub 2018 Apr 17.
4
Lineage- and stage-restricted lentiviral vectors for the gene therapy of chronic granulomatous disease.用于慢性肉芽肿病基因治疗的谱系和阶段限制性慢病毒载体。
Gene Ther. 2011 Nov;18(11):1087-97. doi: 10.1038/gt.2011.65. Epub 2011 May 5.
5
Progress in treating chronic granulomatous disease.慢性肉芽肿病治疗进展。
Br J Haematol. 2021 Jan;192(2):251-264. doi: 10.1111/bjh.16939. Epub 2020 Jul 8.
6
A Review of Chronic Granulomatous Disease.慢性肉芽肿病综述。
Adv Ther. 2017 Dec;34(12):2543-2557. doi: 10.1007/s12325-017-0636-2. Epub 2017 Nov 22.
7
Advances in the treatment of Chronic Granulomatous Disease by gene therapy.基因疗法治疗慢性肉芽肿病的进展。
Curr Gene Ther. 2007 Jun;7(3):155-61. doi: 10.2174/156652307780859044.
8
Gene Therapy for X-Linked Chronic Granulomatous Disease (Net4CGD).X连锁慢性肉芽肿病的基因治疗（Net4CGD）
Hum Gene Ther Clin Dev. 2015 Jun;26(2):88-90. doi: 10.1089/humc.2015.2526.
9
Gene correction of induced pluripotent stem cells derived from a murine model of X-linked chronic granulomatous disorder.对源自X连锁慢性肉芽肿病小鼠模型的诱导多能干细胞进行基因校正。
Methods Mol Biol. 2014;1114:427-40. doi: 10.1007/978-1-62703-761-7_28.
10
[A therapeutic approach towards chronic granulomatous disease].[慢性肉芽肿病的一种治疗方法]
Nihon Rinsho Meneki Gakkai Kaishi. 2014;37(6):437-46. doi: 10.2177/jsci.37.437.
引用本文的文献
1
An Alternatively Translated Isoform of PPARG Suggests AF-1 Domain Inhibition as an Insulin Sensitization Target.PPARG的一种交替翻译异构体表明AF-1结构域抑制作为胰岛素增敏靶点。
Diabetes. 2025 Apr 1;74(4):651-663. doi: 10.2337/db24-0497.
2
Clinical presentation, diagnosis, and treatment of chronic granulomatous disease.慢性肉芽肿病的临床表现、诊断及治疗
Front Pediatr. 2024 Jun 28;12:1384550. doi: 10.3389/fped.2024.1384550. eCollection 2024.
3
Chronic Granulomatous Disease: an Updated Experience, with Emphasis on Newly Recognized Features.慢性肉芽肿病：更新的经验，重点是新认识的特征。
J Clin Immunol. 2022 Oct;42(7):1411-1419. doi: 10.1007/s10875-022-01294-6. Epub 2022 Jun 13.
4
Effects of voriconazole on population pharmacokinetics and optimization of the initial dose of tacrolimus in children with chronic granulomatous disease undergoing hematopoietic stem cell transplantation.伏立康唑对接受造血干细胞移植的慢性肉芽肿病患儿他克莫司群体药代动力学及初始剂量优化的影响
Ann Transl Med. 2021 Sep;9(18):1477. doi: 10.21037/atm-21-4124.
5
Characterization of dental pulp stem cells isolated from a patient diagnosed with Crouzon syndrome.从一名诊断为颅缝早闭综合征患者中分离的牙髓干细胞的特征。
J Cell Physiol. 2021 Jul;236(7):5317-5324. doi: 10.1002/jcp.30241. Epub 2021 Jan 1.
6
Geographic Variability and Pathogen-Specific Considerations in the Diagnosis and Management of Chronic Granulomatous Disease.慢性肉芽肿病诊断与管理中的地理变异性及病原体特异性考量
Pediatric Health Med Ther. 2020 Jul 22;11:257-268. doi: 10.2147/PHMT.S254253. eCollection 2020.
7
NOX Inhibitors: From Bench to Naxibs to Bedside.NOX 抑制剂：从实验室到临床。
Handb Exp Pharmacol. 2021;264:145-168. doi: 10.1007/164_2020_387.
8
Late diagnosis of chronic granulomatous disease.慢性肉芽肿病的迟诊。
Clin Exp Immunol. 2020 Sep;201(3):297-305. doi: 10.1111/cei.13474. Epub 2020 Jul 13.
9
Application of droplet digital PCR for the detection of vector copy number in clinical CAR/TCR T cell products.应用液滴数字 PCR 检测临床 CAR/TCR T 细胞产品中的载体拷贝数。
J Transl Med. 2020 May 8;18(1):191. doi: 10.1186/s12967-020-02358-0.
10
Era of Genomic Medicine: A Narrative Review on CRISPR Technology as a Potential Therapeutic Tool for Human Diseases.基因组医学时代：CRISPR 技术作为人类疾病潜在治疗工具的叙事性综述。
Biomed Res Int. 2019 Oct 7;2019:1369682. doi: 10.1155/2019/1369682. eCollection 2019.
本文引用的文献
1
Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial.同种异体减低强度造血干细胞移植治疗慢性肉芽肿病：单中心前瞻性试验。
J Clin Immunol. 2017 Aug;37(6):548-558. doi: 10.1007/s10875-017-0422-6. Epub 2017 Jul 28.
2
X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stability.X 连锁慢性肉芽肿病携带者：疾病、莱昂化和稳定性。
J Allergy Clin Immunol. 2018 Jan;141(1):365-371. doi: 10.1016/j.jaci.2017.04.035. Epub 2017 May 18.
3
Targeted Repair of CYBB in X-CGD iPSCs Requires Retention of Intronic Sequences for Expression and Functional Correction.对X连锁慢性肉芽肿病诱导多能干细胞中CYBB进行靶向修复需要保留内含子序列以实现表达和功能校正。
Mol Ther. 2017 Feb 1;25(2):321-330. doi: 10.1016/j.ymthe.2016.11.012.
4
CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease.CRISPR-Cas9 基因修复 X 连锁慢性肉芽肿病患者的造血干细胞。
Sci Transl Med. 2017 Jan 11;9(372). doi: 10.1126/scitranslmed.aah3480.
5
Mammalian target of rapamycin inhibition counterbalances the inflammatory status of immune cells in patients with chronic granulomatous disease.雷帕霉素靶蛋白抑制作用可平衡慢性肉芽肿病患者免疫细胞的炎症状态。
J Allergy Clin Immunol. 2017 May;139(5):1641-1649.e6. doi: 10.1016/j.jaci.2016.08.033. Epub 2016 Oct 1.
6
A Comprehensive Approach to the Management of Children and Adults with Chronic Granulomatous Disease.慢性肉芽肿病患儿和成人管理的综合方法。
J Allergy Clin Immunol Pract. 2016 Nov-Dec;4(6):1082-1088. doi: 10.1016/j.jaip.2016.03.021. Epub 2016 May 10.
7
Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency.慢病毒造血干细胞基因疗法治疗X连锁重症联合免疫缺陷病
Sci Transl Med. 2016 Apr 20;8(335):335ra57. doi: 10.1126/scitranslmed.aad8856.
8
Pioglitazone as a novel therapeutic approach in chronic granulomatous disease.吡格列酮作为慢性肉芽肿病的一种新型治疗方法。
J Allergy Clin Immunol. 2016 Jun;137(6):1913-1915.e2. doi: 10.1016/j.jaci.2016.01.033. Epub 2016 Apr 4.
9
Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous disease.在人类CD34(+)造血细胞中进行靶向基因添加以纠正X连锁慢性肉芽肿病。
Nat Biotechnol. 2016 Apr;34(4):424-9. doi: 10.1038/nbt.3513. Epub 2016 Mar 7.
10
Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis.使用重组白细胞介素-1受体拮抗剂阿那白滞素治疗慢性肉芽肿病（CGD）结肠炎患者不太可能诱导持久缓解。
Am J Gastroenterol. 2015 Jun;110(6):938-9. doi: 10.1038/ajg.2015.135.
Zotero 插件